Completed PHASE2 INTERVENTIONAL 4-arm NCT01333709

Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR4)

A Randomized Multicenter Phase 2 Study: a Tailored Strategy for Locally Advanced Rectal Carcinoma

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle

Conditions Locally Advanced Malignant Neoplasm Rectal Carcinoma

Interventions Early tumor response evaluation by MRI volumetry Induction trichemotherapy - FOLFIRINOX regimen Radical proctectomy with total mesorectal excision Radiochemotherapy Cap 50 Radiochemotherapy Cap 60

Updated 5 times since 2017 Last updated: Aug 16, 2017 Started: May 31, 2011 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01333709, this PHASE2 trial focuses on Locally Advanced Malignant Neoplasm and Rectal Carcinoma and remains completed. Sponsored by Institut du Cancer de Montpellier - Val d'Aurelle, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut du Cancer de Montpellier - Val d'Aurelle

Data source: Institut du Cancer de Montpellier - Val d'Aurelle

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montpellier, France